RetInSight Fluid Monitor provides next evolutionary step in monitoring of neovascular age-related macular degeneration

First in class AI-based “fluid activity meter” in nAMD obtains CE Mark

(more…)

RetInSight receives EU Quality Management System certificate according MDR 2017/745

RetInSight, a leader in AI-assisted retinal biomarker image analysis, has received its EU Quality Management System certificate according MDR 2017/745 on December 13, 2021.

(more…)

Topcon Healthcare to Partner with RetInSight

Leveraging artificial intelligence in clinical management of nAMD

Validation of an automated fluid algorithm on real-world data of neovascular age-related macular degeneration over five years

RetInSight successfully passes TÜV SÜD Audit on the way to MDR certification for medical devices / medical device software